|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Thiazolidinedione Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Thiazolidinedione Therapy Alone
|
|
|
Disease Condition |
Metabolic Diseases,Type 2 Diabetes Mellitus, Thiazolidinedione treatment failures
|
|
|
Phase of Trial |
Phase-3
|
Discipline |
Diabetology
|
|
|
Start date of Trial |
2/17/2009
|
Closing Date of Trial |
2/17/2009
|
|
|
|